Skip to content

Is Dietary Nitrate Effective in Reducing Aerobic Glycolysis in Breast Cancer?

Is Dietary Nitrate Effective in Reducing Aerobic Glycolysis (AG) in Breast Cancer? - A Longitudinal Study Using Specialist Magnetic Resonance (MR) Methods

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03944226
Acronym
BEET
Enrollment
1
Registered
2019-05-09
Start date
2019-08-01
Completion date
2022-11-28
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Breast Tissue Neoplasm

Keywords

Beetroot juice, Magnetic Resonance Imaging, Breast cancer

Brief summary

Breast cancer is the most prevalent cancer affecting women, with 1 in 8 women in the UK developing breast cancer in their life time. Chemotherapy drugs, currently used for locally advanced breast cancers, are associated with side effects while dietary supplements have complex effects with a relatively small effect size. Breast tumours have different metabolism compared to healthy tissue, including elevated lactate production by aerobic glycolysis (AG), an underpinning feature of metabolism in breast cancer cells. Dietary nitrate, contained in leafy green vegetables and beetroot, has been shown to improve energy efficiency in exercising skeletal muscle, positioning itself as a disruptor of AG. The purpose of this study is to examine if dietary nitrate can disrupt AG and as a result to halt or even reverse tumour progression and survival. This study will look at scans of breast tumours using magnetic resonance imaging (MRI). Changes to tumour related biochemical substances will be measured by advanced magnetic resonance spectroscopy and changes to tissue structure will be measured by advanced diffusion MRI techniques. In this study, 16 patients undergoing surgery will be recruited for two MRI scans following a 5 day intervention programme.

Detailed description

In this longitudinal study, the investigators propose to examine the changes in lipid composition and microstructure in breast tumours at baseline and post dietary nitrate intervention through the applications of novel non-invasive magnetic resonance spectroscopy (MRS) methods and diffusion and lipid profiling MR imaging methods in patients. The investigators hypothesise that dietary nitrate disrupts tumour progression in breast cancer. 1. Is there a significant difference in lipid composition in the tumour measured by MRS between baseline and post dietary nitrate intervention? 2. Is there a significant difference in lipid composition in the whole breast tissue surrounding tumour measured by MRI between baseline and post dietary nitrate intervention? 3. Is there a significant difference in tissue microstructure measured by MRI between baseline and post dietary nitrate intervention in the breast tissue? To assess the effect of dietary nitrate on tumour progression, paired t-tests will be performed on lipid composition measured from tumour between baseline and post intervention. To assess the effect of dietary nitrate on tumour progression, paired t-tests will be performed on lipid composition in the whole breast tissue surrounding tumour between baseline and post intervention. To assess the effect of dietary nitrate on tissue microstructure paired t-tests will be performed on water displacement measured from tumour between baseline and post intervention.

Interventions

DIETARY_SUPPLEMENTBeetroot juice

The patient will follow a 5 day dietary nitrate intervention programme, taking 3 doses of 7cl (0.4 g nitrate per dose) concentrated beetroot juice (SPORT shot, James White Drinks, Suffolk, U.K.) a day.

Sponsors

University of Aberdeen
Lead SponsorOTHER
NHS Grampian
CollaboratorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Masking description

Single group with no masking

Intervention model description

Single Group: trials with a single arm

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with pathologically confirmed invasive ductal carcinoma (Grade 2 or 3) * Undergoing wide local excision surgery or mastectomy

Exclusion criteria

* Started hormone or chemotherapy treatment before recruitment. * Undergoing treatment for concurrent cancer diagnosis. * Taking antibiotics, proton pump or vegetable dietary supplement.

Design outcomes

Primary

MeasureTime frameDescription
Baseline: Lipid composition in tumourScan one day before intervention (Day 0)Lipid peak volume with units of ratio
Post intervention: Lipid composition in tumourScan one day after completion of intervention (Day 6)Lipid peak volume ratio with units of ratio
Baseline: Lipid composition in whole breast tissue surrounding tumourScan one day before intervention (Day 0)fat fraction with units of %
Post intervention: Lipid composition in whole breast tissue surrounding tumourScan one day after completion of intervention (Day 6)fat fraction with units of %
Baseline: Water displacement in tumourScan one day before intervention (Day 0)Water displacement with units of micrometer
Post intervention: Water displacement in tumourScan one day after completion of intervention (Day 6)Water displacement with units of micrometer

Countries

United Kingdom

Contacts

STUDY_CHAIRJiabao He, PhD

University of Aberdeen

PRINCIPAL_INVESTIGATORVasiliki Mallikourti, MSc

University of Aberdeen

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 1, 2026